Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
New Drugs for Rheumatoid Arthritis | NEJM
B-Cell Targeted Therapies: Clinical Trials Update
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Internet Scientific Publications
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management | European Respiratory Society
Rheumatoid arthritis - The Lancet
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
GPA & MPA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Biological Therapy for Rheumatoid Arthritis - ppt download
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar | Immunotherapy
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Rituximab (Rituxan) | American Journal of Neuroradiology
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
